Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen.
Saito B, Fukuda T, Yokoyama H, Kurosawa S, Takahashi T, Fuji S, Takahashi N, Tajima K, Kim SW, Mori SI, Tanosaki R, Takaue Y, Heike Y. Saito B, et al. Among authors: yokoyama h. Biol Blood Marrow Transplant. 2008 Oct;14(10):1148-1155. doi: 10.1016/j.bbmt.2008.07.013. Biol Blood Marrow Transplant. 2008. PMID: 18804045 Free article.
Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma.
Maruyama D, Watanabe T, Heike Y, Nagase K, Takahashi N, Yamasaki S, Waki F, Yokoyama H, Kim SW, Kobayashi Y, Aizawa S, Tobinai K. Maruyama D, et al. Among authors: yokoyama h. Int J Hematol. 2008 Nov;88(4):396-402. doi: 10.1007/s12185-008-0194-0. Epub 2008 Nov 7. Int J Hematol. 2008. PMID: 18989635
Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission.
Yanada M, Kurosawa S, Yamaguchi T, Yamashita T, Moriuchi Y, Ago H, Takeuchi J, Nakamae H, Taguchi J, Sakura T, Takamatsu Y, Waki F, Yokoyama H, Watanabe M, Emi N, Fukuda T. Yanada M, et al. Among authors: yokoyama h. Haematologica. 2012 Jun;97(6):915-8. doi: 10.3324/haematol.2011.058289. Epub 2011 Dec 16. Haematologica. 2012. PMID: 22180431 Free PMC article.
Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Takami A, Yano S, Yokoyama H, Kuwatsuka Y, Yamaguchi T, Kanda Y, Morishima Y, Fukuda T, Miyazaki Y, Nakamae H, Tanaka J, Atsuta Y, Kanamori H. Takami A, et al. Among authors: yokoyama h. Biol Blood Marrow Transplant. 2014 Nov;20(11):1785-90. doi: 10.1016/j.bbmt.2014.07.010. Epub 2014 Jul 14. Biol Blood Marrow Transplant. 2014. PMID: 25034960 Free article.
Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation.
Yano S, Mori S, Saito T, Yokoyama H, Machishima T, Shimada T, Yahagi Y, Sugiyama K, Ogasawara Y, Takahara S, Kasama K, Katsube A, Kamiyama Y, Suzuki K, Inui Y, Usui N, Aiba K, Yamashita T. Yano S, et al. Among authors: yokoyama h. Ann Hematol. 2015 Mar;94(3):491-6. doi: 10.1007/s00277-014-2233-7. Epub 2014 Oct 19. Ann Hematol. 2015. PMID: 25325985 Clinical Trial.
Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission.
Yano S, Yokoyama H, Yanada M, Mori J, Aoki J, Ohashi K, Kanomori H, Ozawa Y, Sawa M, Nakamae H, Eto T, Ohta S, Tanaka J, Ichinohe T, Atsuta Y, Takami A. Yano S, et al. Among authors: yokoyama h. Bone Marrow Transplant. 2019 Dec;54(12):2004-2012. doi: 10.1038/s41409-019-0571-8. Epub 2019 May 31. Bone Marrow Transplant. 2019. PMID: 31152148
2,465 results